About PSM

PSM applauds the members of the House of Representatives for passing HR 1919, “Safeguarding America’s Pharmaceuticals Act of 2013.”

Today, our system of prescription drug distribution heavily relies on trusting the entity you’re dealing with and their judgment. If a mistake is made, or anyone farther back in the supply chain makes a mistake in purchasing a substandard drug product, there is no ability for a good actor down the line to know this. Criminals have taken advantage of this fact, and such incidents are growing in number every year. Life-saving medications that treat osteoporosis, cancer, heart disease, and many other serious medical conditions have been faked just in the last few years, as the rules of the road have failed to keep up with the innovative nature of the criminals that prey on American patients.

[...]

Dear Speaker Boehner and Chairman Upton:

On behalf of the Partnership for Safe Medicines (PSM), we write today in strong support of H.R.
1919, the “Safeguarding America’s Pharmaceuticals Act”.

PSM is a not for profit, consumer focused organization that seeks to
keep Americans safe from counterfeit drugs through patient and healthcare
provider education and awareness.   In
the US we work with a coalition of over 70 healthcare professional and patient
groups to improve  patients’ and their
healthcare providers’ knowledge about where they obtain their medication, how
they can save money safely, and how to safely identify licensed pharmaceutical
distributors.

PSM strongly supports the creation of a national uniform track and trace
or pedigree system that would allow all participants in the supply chain to
verify a product’s history of sale. 

March
12, 2013 (Washington, D.C.) – The Partnership for Safe Medicines
(PSM), the leading advocacy organization dedicated to fighting the spread of
counterfeit drugs, applauds today’s
announcement of a bold new initiative between INTERPOL
and the pharmaceutical industry to combat the global health threat of
counterfeit and fake medicines.

This new initiative broadens the scope of the
successful Medical Product Counterfeiting and Pharmaceutical Crime Unit through
the creation of a Pharmaceutical Crime Program to assist and enhance worldwide
law enforcement efforts. Thomas Kubic, PSM Board Member and CEO of the
Pharmaceutical Security Institute, released the following statement hailing the
new agreement:

Launch of PSM China Reinforces Global
Fight Against Counterfeit Drugs

Beijing and Washington, D.C. (November
28, 2012) – The
Partnership for Safe Medicines (PSM), the leading advocacy organization dedicated
to fighting the global threat posed by counterfeit drugs, today announced its
latest international collaboration with the launch of PSM China. Today’s launch
event in Beijing was attended by stakeholders from the government, advocacy community and industry, and underscores the important
role that public-private partnerships play in educating consumers and helping
to keep them safe from dangerous and deadly counterfeit medicines.